Internal Medicine, Endocrinology, Diabetes, & Metabolism · Manati, PR
NPI
1649391707
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
Rr 2 Box 7066
Manati, PR, 00674
Phone (787) 299-1067
Medicare paid, 2024
$8,312
161 services
Medicare patients, 2024
67
Average age 73
Drug cost, 2024
$3.9M
17,579 prescriptions
Company payments, 2025
$211
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mirna Maldonado Vega was code 99213 (office e&m - established), 104 times for 62 patients. In total Mirna Maldonado Vega billed 161 services in 5 codes, and Medicare paid $8,312.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-08-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 104 | 62 | $52.19 | $5,428 |
| 99214 Office E&M - Established | Office | 24 | 20 | $96.53 | $2,317 |
| 99211 Office E&M - Established | Office | 22 | 20 | $14.77 | $325 |
By year: 2022 $9,695 for 197 services; 2023 $9,126 for 166 services; 2024 $8,312 for 161 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mirna Maldonado Vega prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 2,788 prescriptions and refills. In total Mirna Maldonado Vega wrote 17,579 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 2,788 | 6,291 | 652 | $278K |
| Glimepiride Generic | 916 | 2,302 | 275 | $24K |
| Metformin Hcl Generic | 859 | 2,119 | 265 | $6,612 |
| Simvastatin Generic | 539 | 1,319 | 178 | $4,042 |
| Rosuvastatin Calcium Generic | 512 | 1,224 | 174 | $7,162 |
| Atorvastatin Calcium Generic | 484 | 1,265 | 189 | $6,458 |
| Ozempic Semaglutide | 451 | 565 | 79 | $546K |
| Ezetimibe Generic | 444 | 1,152 | 173 | $9,869 |
| Alendronate Sodium Generic | 412 | 959 | 143 | $4,294 |
| Lantus Insulin Glargine,hum.Rec.Anlog | 402 | 764 | 108 | $72K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 388 | 594 | 85 | $361K |
| Humalog Insulin Lispro | 380 | 553 | 85 | $86K |
| Farxiga Dapagliflozin Propanediol | 353 | 622 | 87 | $359K |
| Glipizide Er Glipizide | 332 | 814 | 88 | $15K |
| Janumet Sitagliptin Phos/Metformin Hcl | 322 | 517 | 83 | $284K |
Brand drugs: 7,353 claims; generic drugs: 9,566 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mirna Maldonado Vega $211 ($211 in general payments such as food, travel and fees) from 3 companies. The largest payer was Eli Lilly Export S.A. Puerto Rico Branch with $148.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.